Barely Significant
← all excerpts

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.

PLoS One · 2024 · PMC11290656 · PMID 39083541

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

borderline significantP = 0.01actually significant
This comparison for CD3+IT-CD8 was borderline significant ( P = 0.01) ( Fig 2F ).

also in 1,379 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.